CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
$2.89 -0.12 (-3.9867%)
Analysed CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) News Sources
Analysts Adjust Cadrenal Therapeutics, Inc. (CVKD) Valuation After Including CAD-1005 Program
21-04-2026
yahoo.com
Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
30-04-2026
yahoo.com
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07-05-2026
yahoo.com
CVKD: Designing Phase 3 Trial for CAD-1005 in HIT
08-05-2026
yahoo.com
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
19-05-2026
yahoo.com
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
03-06-2026
yahoo.com
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
15-06-2026
yahoo.com
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
18-06-2026
yahoo.com
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
24-06-2026
yahoo.com
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
01-07-2026
yahoo.com
What is the current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The current price of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is $2.89.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is $-0.12.
CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) since the previous trading day is -3.9867%.
What is the most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent average sentiment score for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)?
The most recent sentiment for CADRENAL THERAPEUTICS INC (CVKD:NASDAQ) is .
SEC-8K** Filing Available For CADRENAL THERAPEUTICS INC (CVKD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.